| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 1.67e-08 | 3 | 52 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 1.66e-07 | 5 | 52 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | TAP complex binding | 1.38e-06 | 9 | 52 | 3 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 1.38e-06 | 9 | 52 | 3 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.97e-06 | 10 | 52 | 3 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.97e-06 | 10 | 52 | 3 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.97e-06 | 10 | 52 | 3 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 3.60e-06 | 12 | 52 | 3 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.10e-05 | 17 | 52 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.84e-05 | 20 | 52 | 3 | GO:0042608 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 7.83e-05 | 32 | 52 | 3 | GO:0042288 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.49e-04 | 310 | 52 | 6 | GO:0030246 | |
| GeneOntologyMolecularFunction | NADH dehydrogenase (ubiquinone) activity | 1.66e-04 | 41 | 52 | 3 | GO:0008137 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 1.78e-04 | 42 | 52 | 3 | GO:0071889 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 2.82e-04 | 49 | 52 | 3 | GO:0042605 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 4.19e-04 | 56 | 52 | 3 | GO:0030170 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 4.41e-04 | 57 | 52 | 3 | GO:0070279 | |
| GeneOntologyMolecularFunction | MHC protein binding | 4.65e-04 | 58 | 52 | 3 | GO:0042287 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 5.13e-04 | 60 | 52 | 3 | GO:0016655 | |
| GeneOntologyMolecularFunction | oxidoreduction-driven active transmembrane transporter activity | 7.73e-04 | 69 | 52 | 3 | GO:0015453 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 9.55e-04 | 793 | 52 | 8 | GO:0015075 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.10e-03 | 301 | 52 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.14e-03 | 627 | 52 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.18e-03 | 178 | 52 | 4 | GO:0015399 | |
| GeneOntologyMolecularFunction | AMP binding | 1.35e-03 | 21 | 52 | 2 | GO:0016208 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.59e-03 | 664 | 52 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 1.95e-03 | 95 | 52 | 3 | GO:0016651 | |
| GeneOntologyMolecularFunction | acyl-CoA binding | 2.08e-03 | 26 | 52 | 2 | GO:0120227 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 2.41e-03 | 28 | 52 | 2 | GO:0005251 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 3.34e-03 | 758 | 52 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | electron transfer activity | 4.14e-03 | 124 | 52 | 3 | GO:0009055 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 4.40e-03 | 38 | 52 | 2 | GO:0034061 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 7.91e-07 | 8 | 51 | 3 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 7.80e-06 | 16 | 51 | 3 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 9.45e-06 | 17 | 51 | 3 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 9.45e-06 | 17 | 51 | 3 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.13e-05 | 18 | 51 | 3 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.13e-05 | 18 | 51 | 3 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 2.44e-05 | 23 | 51 | 3 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 3.15e-05 | 25 | 51 | 3 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 3.15e-05 | 25 | 51 | 3 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 6.72e-05 | 32 | 51 | 3 | GO:0019883 | |
| GeneOntologyBiologicalProcess | glycogen catabolic process | 8.81e-05 | 35 | 51 | 3 | GO:0005980 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by endothelin | 8.93e-05 | 6 | 51 | 2 | GO:0003100 | |
| GeneOntologyBiologicalProcess | glucan catabolic process | 9.60e-05 | 36 | 51 | 3 | GO:0009251 | |
| GeneOntologyBiologicalProcess | polysaccharide catabolic process | 1.13e-04 | 38 | 51 | 3 | GO:0000272 | |
| GeneOntologyBiologicalProcess | mitochondrial respiratory chain complex assembly | 1.37e-04 | 106 | 51 | 4 | GO:0033108 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 1.42e-04 | 41 | 51 | 3 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 1.53e-04 | 42 | 51 | 3 | GO:0001916 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 2.13e-04 | 9 | 51 | 2 | GO:0042270 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 2.28e-04 | 48 | 51 | 3 | GO:0002478 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by hormone | 2.73e-04 | 51 | 51 | 3 | GO:0001990 | |
| GeneOntologyBiologicalProcess | mitochondrial electron transport, NADH to ubiquinone | 2.89e-04 | 52 | 51 | 3 | GO:0006120 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 3.06e-04 | 53 | 51 | 3 | GO:0001914 | |
| GeneOntologyBiologicalProcess | proteoglycan catabolic process | 3.25e-04 | 11 | 51 | 2 | GO:0030167 | |
| GeneOntologyBiologicalProcess | energy derivation by oxidation of organic compounds | 3.60e-04 | 385 | 51 | 6 | GO:0015980 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 3.99e-04 | 58 | 51 | 3 | GO:0019884 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure mediated by a chemical signal | 4.63e-04 | 61 | 51 | 3 | GO:0003044 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5.15e-04 | 150 | 51 | 4 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 5.15e-04 | 150 | 51 | 4 | GO:0002708 | |
| GeneOntologyBiologicalProcess | mitochondrial respiratory chain complex I assembly | 5.84e-04 | 66 | 51 | 3 | GO:0032981 | |
| GeneOntologyBiologicalProcess | NADH dehydrogenase complex assembly | 5.84e-04 | 66 | 51 | 3 | GO:0010257 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 6.41e-04 | 159 | 51 | 4 | GO:0002821 | |
| GeneOntologyBiologicalProcess | proton motive force-driven mitochondrial ATP synthesis | 6.65e-04 | 69 | 51 | 3 | GO:0042776 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 6.94e-04 | 70 | 51 | 3 | GO:0001913 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 8.05e-04 | 169 | 51 | 4 | GO:0010977 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 8.16e-04 | 74 | 51 | 3 | GO:0002711 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 8.82e-04 | 76 | 51 | 3 | GO:0048002 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 9.17e-04 | 175 | 51 | 4 | GO:0002705 | |
| GeneOntologyBiologicalProcess | protein autoubiquitination | 9.51e-04 | 78 | 51 | 3 | GO:0051865 | |
| GeneOntologyBiologicalProcess | heart valve development | 9.51e-04 | 78 | 51 | 3 | GO:0003170 | |
| GeneOntologyBiologicalProcess | proton motive force-driven ATP synthesis | 9.51e-04 | 78 | 51 | 3 | GO:0015986 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 9.87e-04 | 79 | 51 | 3 | GO:0001912 | |
| GeneOntologyBiologicalProcess | detection of bacterium | 1.11e-03 | 20 | 51 | 2 | GO:0016045 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 1.35e-03 | 88 | 51 | 3 | GO:0031343 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 5.05e-07 | 7 | 52 | 3 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 1.72e-06 | 10 | 52 | 3 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 5.18e-06 | 14 | 52 | 3 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 9.63e-06 | 17 | 52 | 3 | GO:0033106 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 2.48e-05 | 23 | 52 | 3 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 3.63e-05 | 26 | 52 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 8.98e-05 | 35 | 52 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.56e-04 | 42 | 52 | 3 | GO:0070971 | |
| GeneOntologyCellularComponent | lysosome | 1.57e-04 | 811 | 52 | 9 | GO:0005764 | |
| GeneOntologyCellularComponent | lytic vacuole | 1.57e-04 | 811 | 52 | 9 | GO:0000323 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 1.62e-04 | 110 | 52 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 1.73e-04 | 112 | 52 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 2.32e-04 | 48 | 52 | 3 | GO:0098576 | |
| GeneOntologyCellularComponent | membrane raft | 2.69e-04 | 362 | 52 | 6 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 2.77e-04 | 364 | 52 | 6 | GO:0098857 | |
| GeneOntologyCellularComponent | NADH dehydrogenase complex | 2.94e-04 | 52 | 52 | 3 | GO:0030964 | |
| GeneOntologyCellularComponent | respiratory chain complex I | 2.94e-04 | 52 | 52 | 3 | GO:0045271 | |
| GeneOntologyCellularComponent | vacuole | 3.77e-04 | 913 | 52 | 9 | GO:0005773 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 5.43e-04 | 64 | 52 | 3 | GO:0012507 | |
| GeneOntologyCellularComponent | lysosomal membrane | 9.71e-04 | 462 | 52 | 6 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 9.71e-04 | 462 | 52 | 6 | GO:0098852 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 1.16e-03 | 83 | 52 | 3 | GO:0030670 | |
| GeneOntologyCellularComponent | axolemma | 1.24e-03 | 21 | 52 | 2 | GO:0030673 | |
| GeneOntologyCellularComponent | cis-Golgi network | 1.24e-03 | 85 | 52 | 3 | GO:0005801 | |
| GeneOntologyCellularComponent | axon | 1.50e-03 | 891 | 52 | 8 | GO:0030424 | |
| GeneOntologyCellularComponent | cell surface | 1.53e-03 | 1111 | 52 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | vacuolar membrane | 1.56e-03 | 507 | 52 | 6 | GO:0005774 | |
| GeneOntologyCellularComponent | respiratory chain complex | 1.76e-03 | 96 | 52 | 3 | GO:0098803 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.83e-03 | 523 | 52 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | early endosome membrane | 1.90e-03 | 212 | 52 | 4 | GO:0031901 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.90e-03 | 212 | 52 | 4 | GO:0030666 | |
| GeneOntologyCellularComponent | coated vesicle | 1.97e-03 | 360 | 52 | 5 | GO:0030135 | |
| GeneOntologyCellularComponent | recycling endosome | 2.25e-03 | 222 | 52 | 4 | GO:0055037 | |
| GeneOntologyCellularComponent | transporter complex | 2.35e-03 | 550 | 52 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | secretory granule | 3.36e-03 | 1014 | 52 | 8 | GO:0030141 | |
| GeneOntologyCellularComponent | mitochondrial inner membrane | 3.42e-03 | 593 | 52 | 6 | GO:0005743 | |
| GeneOntologyCellularComponent | calyx of Held | 3.62e-03 | 36 | 52 | 2 | GO:0044305 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 3.64e-03 | 124 | 52 | 3 | GO:1904813 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 3.73e-03 | 125 | 52 | 3 | GO:0140534 | |
| GeneOntologyCellularComponent | Golgi cisterna | 4.62e-03 | 135 | 52 | 3 | GO:0031985 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 5.13e-03 | 43 | 52 | 2 | GO:0032809 | |
| GeneOntologyCellularComponent | organelle inner membrane | 5.42e-03 | 652 | 52 | 6 | GO:0019866 | |
| GeneOntologyCellularComponent | cell body membrane | 6.11e-03 | 47 | 52 | 2 | GO:0044298 | |
| GeneOntologyCellularComponent | early endosome | 6.75e-03 | 481 | 52 | 5 | GO:0005769 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 7.02e-03 | 157 | 52 | 3 | GO:0045335 | |
| GeneOntologyCellularComponent | oxidoreductase complex | 7.52e-03 | 161 | 52 | 3 | GO:1990204 | |
| GeneOntologyCellularComponent | dendrite membrane | 8.58e-03 | 56 | 52 | 2 | GO:0032590 | |
| GeneOntologyCellularComponent | secretory granule lumen | 8.64e-03 | 325 | 52 | 4 | GO:0034774 | |
| GeneOntologyCellularComponent | Golgi membrane | 8.72e-03 | 721 | 52 | 6 | GO:0000139 | |
| GeneOntologyCellularComponent | Golgi stack | 8.86e-03 | 171 | 52 | 3 | GO:0005795 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 9.10e-03 | 330 | 52 | 4 | GO:0060205 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 9.21e-03 | 519 | 52 | 5 | GO:0009897 | |
| GeneOntologyCellularComponent | vesicle lumen | 9.29e-03 | 332 | 52 | 4 | GO:0031983 | |
| GeneOntologyCellularComponent | membrane protein complex | 1.09e-02 | 1498 | 52 | 9 | GO:0098796 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 1.10e-02 | 185 | 52 | 3 | GO:0101002 | |
| GeneOntologyCellularComponent | secretory vesicle | 1.13e-02 | 1246 | 52 | 8 | GO:0099503 | |
| MousePheno | spinal cord inflammation | 1.40e-06 | 8 | 42 | 3 | MP:0030987 | |
| MousePheno | CNS inflammation | 2.00e-05 | 54 | 42 | 4 | MP:0006082 | |
| Domain | PHOSPHORYLASE | 1.81e-08 | 3 | 50 | 3 | PS00102 | |
| Domain | Phosphorylase | 1.81e-08 | 3 | 50 | 3 | PF00343 | |
| Domain | Glycg_phsphrylas | 1.81e-08 | 3 | 50 | 3 | IPR011833 | |
| Domain | Glyco_trans_35 | 1.81e-08 | 3 | 50 | 3 | IPR000811 | |
| Domain | MHC_I_a_C | 3.59e-07 | 6 | 50 | 3 | IPR010579 | |
| Domain | MHC_I_C | 3.59e-07 | 6 | 50 | 3 | PF06623 | |
| Domain | MHC_I | 2.32e-05 | 21 | 50 | 3 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 2.32e-05 | 21 | 50 | 3 | IPR001039 | |
| Domain | - | 3.51e-05 | 24 | 50 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 3.51e-05 | 24 | 50 | 3 | IPR011161 | |
| Domain | K_chnl_volt-dep_Kv3 | 4.20e-05 | 4 | 50 | 2 | IPR003974 | |
| Domain | MHC_I/II-like_Ag-recog | 1.43e-04 | 38 | 50 | 3 | IPR011162 | |
| Domain | C1-set | 4.07e-04 | 54 | 50 | 3 | PF07654 | |
| Domain | IGc1 | 4.53e-04 | 56 | 50 | 3 | SM00407 | |
| Domain | Ig_C1-set | 5.02e-04 | 58 | 50 | 3 | IPR003597 | |
| Domain | Ig/MHC_CS | 5.02e-04 | 58 | 50 | 3 | IPR003006 | |
| Domain | IG_MHC | 5.55e-04 | 60 | 50 | 3 | PS00290 | |
| Domain | K_chnl_volt-dep_Kv | 2.36e-03 | 27 | 50 | 2 | IPR003968 | |
| Domain | VG_K_chnl | 3.52e-03 | 33 | 50 | 2 | IPR028325 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 5.25e-07 | 6 | 43 | 3 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 9.17e-07 | 7 | 43 | 3 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 9.17e-07 | 7 | 43 | 3 | M47530 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION | 2.19e-06 | 9 | 43 | 3 | M47621 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 2.19e-06 | 9 | 43 | 3 | MM14527 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 4.29e-06 | 11 | 43 | 3 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 5.71e-06 | 12 | 43 | 3 | M47529 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 9.40e-06 | 14 | 43 | 3 | M19193 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.83e-05 | 52 | 43 | 4 | M14171 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 2.09e-05 | 18 | 43 | 3 | MM14525 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 2.12e-05 | 54 | 43 | 4 | MM14871 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | HLA-A HLA-B HLA-C GUSB DTX4 BTK PYGB PYGL OLR1 NOS3 CTSZ FBXW11 | 2.83e-05 | 995 | 43 | 12 | MM14661 |
| Pathway | BIOCARTA_CTL_PATHWAY | 2.91e-05 | 20 | 43 | 3 | MM1374 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MITOCHONDRIAL_COMPLEX_UCP1_IN_THERMOGENESIS | 3.68e-05 | 62 | 43 | 4 | M47970 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 5.80e-05 | 25 | 43 | 3 | M27857 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 5.80e-05 | 25 | 43 | 3 | MM1465 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 5.80e-05 | 25 | 43 | 3 | MM15713 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 9.14e-05 | 29 | 43 | 3 | M1062 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 1.34e-04 | 511 | 43 | 8 | MM15330 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 1.48e-04 | 34 | 43 | 3 | MM15985 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.91e-04 | 37 | 43 | 3 | M18615 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 2.41e-04 | 40 | 43 | 3 | M39595 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 2.60e-04 | 41 | 43 | 3 | M13519 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 2.96e-04 | 431 | 43 | 7 | M39729 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 2.97e-04 | 106 | 43 | 4 | M518 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 3.00e-04 | 43 | 43 | 3 | M12617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_I | 3.21e-04 | 44 | 43 | 3 | M47683 | |
| Pathway | BIOCARTA_FEEDER_PATHWAY | 3.23e-04 | 9 | 43 | 2 | M3061 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TDP43_TO_ELECTRON_TRANSFER_IN_COMPLEX_I | 3.43e-04 | 45 | 43 | 3 | M47741 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I | 3.43e-04 | 45 | 43 | 3 | M47705 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_ELECTRON_TRANSFER_IN_COMPLEX_I | 3.43e-04 | 45 | 43 | 3 | M47706 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 3.66e-04 | 46 | 43 | 3 | M27151 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 4.32e-04 | 1128 | 43 | 11 | M1036 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I | 4.97e-04 | 51 | 43 | 3 | M47685 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 5.26e-04 | 52 | 43 | 3 | M13103 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 5.51e-04 | 478 | 43 | 7 | M27620 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 6.27e-04 | 129 | 43 | 4 | M39693 | |
| Pathway | WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM | 6.55e-04 | 56 | 43 | 3 | M39781 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 8.08e-04 | 14 | 43 | 2 | MM15391 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 8.82e-04 | 62 | 43 | 3 | M39639 | |
| Pathway | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | 8.98e-04 | 142 | 43 | 4 | MM15309 | |
| Pathway | WP_TAR_SYNDROME | 9.24e-04 | 63 | 43 | 3 | M48082 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 9.80e-04 | 381 | 43 | 6 | M1066 | |
| Pathway | REACTOME_COMPLEX_I_BIOGENESIS | 1.01e-03 | 65 | 43 | 3 | MM15331 | |
| Pathway | REACTOME_COMPLEX_I_BIOGENESIS | 1.15e-03 | 68 | 43 | 3 | M27621 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.26e-03 | 70 | 43 | 3 | M12294 | |
| Pathway | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | 1.33e-03 | 158 | 43 | 4 | M893 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 1.35e-03 | 18 | 43 | 2 | MM15577 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 1.59e-03 | 76 | 43 | 3 | MM14526 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 1.72e-03 | 78 | 43 | 3 | M973 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.75e-03 | 288 | 43 | 5 | M16864 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 2.42e-03 | 88 | 43 | 3 | M16004 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 2.50e-03 | 89 | 43 | 3 | M39398 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 3.29e-03 | 98 | 43 | 3 | M965 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 3.73e-03 | 343 | 43 | 5 | MM15712 | |
| Pathway | WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA | 3.99e-03 | 105 | 43 | 3 | M39417 | |
| Pathway | WP_ENDOTHELIN_PATHWAYS | 4.52e-03 | 33 | 43 | 2 | M39651 | |
| Pubmed | 6.02e-10 | 9 | 53 | 4 | 9751712 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 23246585 | ||
| Pubmed | The detailed distribution of HLA-A, B, C antigens in normal human organs. | 3.34e-09 | 3 | 53 | 3 | 6591601 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 11390610 | ||
| Pubmed | HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. | 3.34e-09 | 3 | 53 | 3 | 19694795 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 16129034 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 15301865 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 15662734 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 15480178 | ||
| Pubmed | HLA-C(*)03 is a risk factor for cardiomyopathy in Chagas disease. | 3.34e-09 | 3 | 53 | 3 | 11053636 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 33968060 | ||
| Pubmed | The role of HLA class I gene variation in autoimmune diabetes. | 3.34e-09 | 3 | 53 | 3 | 17491685 | |
| Pubmed | Association of human leukocyte antigen class I antigens in Iranian patients with pemphigus vulgaris. | 3.34e-09 | 3 | 53 | 3 | 23330836 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 25495410 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 21209113 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 19774073 | ||
| Pubmed | Serological HLA class I alleles in Senegalese blood donors detected HBs Ag positive. | 3.34e-09 | 3 | 53 | 3 | 11064107 | |
| Pubmed | HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. | 3.34e-09 | 3 | 53 | 3 | 17878955 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 24158818 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 18684953 | ||
| Pubmed | Allelic distribution of HLA class I genes in the Tibetan ethnic population of China. | 3.34e-09 | 3 | 53 | 3 | 17117954 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 17909631 | ||
| Pubmed | Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C. | 3.34e-09 | 3 | 53 | 3 | 10715516 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 15982258 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 21482733 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 15009803 | ||
| Pubmed | Polymorphism of HLA class I genes in Meizhou Han population of Guangdong, China. | 3.34e-09 | 3 | 53 | 3 | 17373939 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 15140038 | ||
| Pubmed | [Association of HLA class I and leukemia in mestizo patients of the state of Zulia, Venezuela]. | 3.34e-09 | 3 | 53 | 3 | 14727382 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 33863792 | ||
| Pubmed | Host genetics and HIV-1 viral load set-point in African-Americans. | 3.34e-09 | 3 | 53 | 3 | 19276793 | |
| Pubmed | Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease. | 3.34e-09 | 3 | 53 | 3 | 14501786 | |
| Pubmed | Human leukocyte antigens as genetic markers in Greek patients with sporadic pancreatic cancer. | 3.34e-09 | 3 | 53 | 3 | 15211110 | |
| Pubmed | Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. | 3.34e-09 | 3 | 53 | 3 | 20660184 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 18082573 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 16451198 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 17504510 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 22826228 | ||
| Pubmed | HLA-A, HLA-B and HLA-C polymorphism in the Slovak population. | 3.34e-09 | 3 | 53 | 3 | 10954160 | |
| Pubmed | Association between HLA inheritance and asthma medication use in HIV positive children. | 3.34e-09 | 3 | 53 | 3 | 20613458 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 24554773 | ||
| Pubmed | Association of HLA class I alleles with psoriasis vulgaris in southeastern Chinese Hans. | 3.34e-09 | 3 | 53 | 3 | 14527733 | |
| Pubmed | Association of human leukocyte antigen and esophageal cancer in North of Iran. | 3.34e-09 | 3 | 53 | 3 | 20334121 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 9104816 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 20504258 | ||
| Pubmed | Distributions of HLA class I alleles and haplotypes in Northern Han Chinese. | 3.34e-09 | 3 | 53 | 3 | 16185325 | |
| Pubmed | Locus-specific constitutive and cytokine-induced HLA class I gene expression. | 3.34e-09 | 3 | 53 | 3 | 12574356 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 18074415 | ||
| Pubmed | [Haplotype and linkage analysis of HLA-I classical genes in Chinese Han population]. | 3.34e-09 | 3 | 53 | 3 | 17956696 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 6585830 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 18097038 | ||
| Pubmed | Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage. | 3.34e-09 | 3 | 53 | 3 | 11927505 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 19663693 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 28278336 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 16331510 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 20219611 | ||
| Pubmed | HIV and human leukocyte antigen association--the Indian scenario. | 3.34e-09 | 3 | 53 | 3 | 15534563 | |
| Pubmed | HLA B*44: protective effects in MS susceptibility and MRI outcome measures. | 3.34e-09 | 3 | 53 | 3 | 20713950 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 15245377 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 15245373 | ||
| Pubmed | Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples. | 3.34e-09 | 3 | 53 | 3 | 15220037 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 18580606 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 11120862 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 22553319 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 18434400 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 17471440 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 8617941 | ||
| Pubmed | HLA diversity among Nadars, a primitive Dravidian caste of South India. | 3.34e-09 | 3 | 53 | 3 | 14617038 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 24717292 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 20065064 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 28650991 | ||
| Pubmed | Novel HLA Class I Alleles Associated with Indian Leprosy Patients. | 3.34e-09 | 3 | 53 | 3 | 12975536 | |
| Pubmed | Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejection. | 3.34e-09 | 3 | 53 | 3 | 17207712 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 19232441 | ||
| Pubmed | Association of HLA class I alleles with keloids in Chinese Han individuals. | 3.34e-09 | 3 | 53 | 3 | 19932885 | |
| Pubmed | HLA class I polymorphism, as characterised by PCR-SSOP, in a Brazilian exogamic population. | 3.34e-09 | 3 | 53 | 3 | 11144289 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 15807454 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 11543903 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 25781986 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 18521626 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 12372094 | ||
| Pubmed | Evolutionary relationship between immunoglobulins and transplantation antigens. | 3.34e-09 | 3 | 53 | 3 | 1055432 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 1317015 | ||
| Pubmed | Association of HLA class I alleles with aloplecia areata in Chinese Hans. | 3.34e-09 | 3 | 53 | 3 | 16185849 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 33421092 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 21352198 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 11182228 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 36605212 | ||
| Pubmed | Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese. | 3.34e-09 | 3 | 53 | 3 | 17258541 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 15072129 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 19019964 | ||
| Pubmed | HLA class I polymorphism in Mongolian and Hui ethnic groups from Northern China. | 3.34e-09 | 3 | 53 | 3 | 17462512 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 19054371 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 12594841 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 25193656 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 12651075 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 24046013 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 11861287 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 20946353 | ||
| Pubmed | Haplotype associations of the major histocompatibility complex with psoriasis in Northeastern Thais. | 1.34e-08 | 4 | 53 | 3 | 12100686 | |
| Interaction | HLA-DQB1 interactions | 5.86e-08 | 82 | 51 | 6 | int:HLA-DQB1 | |
| Interaction | DNAJC30 interactions | 1.18e-06 | 217 | 51 | 7 | int:DNAJC30 | |
| Interaction | LILRB1 interactions | 1.81e-06 | 10 | 51 | 3 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 1.81e-06 | 10 | 51 | 3 | int:LILRB2 | |
| Interaction | FUT1 interactions | 2.02e-06 | 36 | 51 | 4 | int:FUT1 | |
| Interaction | GPR34 interactions | 8.35e-06 | 16 | 51 | 3 | int:GPR34 | |
| Interaction | HLA-G interactions | 1.20e-05 | 118 | 51 | 5 | int:HLA-G | |
| Interaction | IRAK1 interactions | 1.52e-05 | 320 | 51 | 7 | int:IRAK1 | |
| Interaction | GPRASP2 interactions | 1.65e-05 | 126 | 51 | 5 | int:GPRASP2 | |
| Interaction | HLA-DQA1 interactions | 2.30e-05 | 135 | 51 | 5 | int:HLA-DQA1 | |
| Interaction | CD1A interactions | 3.30e-05 | 72 | 51 | 4 | int:CD1A | |
| Interaction | CD8A interactions | 3.81e-05 | 26 | 51 | 3 | int:CD8A | |
| Interaction | CD1B interactions | 4.30e-05 | 77 | 51 | 4 | int:CD1B | |
| Interaction | KIR3DL3 interactions | 5.91e-05 | 30 | 51 | 3 | int:KIR3DL3 | |
| Interaction | CYP2J2 interactions | 5.91e-05 | 30 | 51 | 3 | int:CYP2J2 | |
| Interaction | OGFOD3 interactions | 7.19e-05 | 32 | 51 | 3 | int:OGFOD3 | |
| Interaction | HSPB8 interactions | 7.30e-05 | 172 | 51 | 5 | int:HSPB8 | |
| Interaction | RHOG interactions | IARS2 SLC12A4 HLA-A HLA-B CDC123 MRPS18B POLG ACBD5 LRRC8A OLR1 | 7.94e-05 | 910 | 51 | 10 | int:RHOG |
| Interaction | RHOC interactions | 1.01e-04 | 584 | 51 | 8 | int:RHOC | |
| Interaction | YBEY interactions | 1.15e-04 | 99 | 51 | 4 | int:YBEY | |
| Interaction | TMEM106B interactions | 1.25e-04 | 309 | 51 | 6 | int:TMEM106B | |
| Interaction | PIGX interactions | 1.31e-04 | 7 | 51 | 2 | int:PIGX | |
| Interaction | PRKAR1A interactions | 1.39e-04 | 315 | 51 | 6 | int:PRKAR1A | |
| Interaction | NDUFB4 interactions | 1.39e-04 | 104 | 51 | 4 | int:NDUFB4 | |
| Interaction | RAC3 interactions | 1.50e-04 | 619 | 51 | 8 | int:RAC3 | |
| Interaction | HTR3A interactions | 1.61e-04 | 108 | 51 | 4 | int:HTR3A | |
| Interaction | NDUFS7 interactions | 2.13e-04 | 341 | 51 | 6 | int:NDUFS7 | |
| Interaction | TCEAL4 interactions | 2.15e-04 | 46 | 51 | 3 | int:TCEAL4 | |
| Interaction | PKD1L1-AS1 interactions | 2.23e-04 | 9 | 51 | 2 | int:PKD1L1-AS1 | |
| Interaction | ENPP6 interactions | 2.29e-04 | 47 | 51 | 3 | int:ENPP6 | |
| Interaction | PARL interactions | 2.36e-04 | 221 | 51 | 5 | int:PARL | |
| Interaction | HEATR1 interactions | 2.41e-04 | 222 | 51 | 5 | int:HEATR1 | |
| Interaction | RAD23A interactions | 2.51e-04 | 224 | 51 | 5 | int:RAD23A | |
| Interaction | TMEM70 interactions | 2.57e-04 | 225 | 51 | 5 | int:TMEM70 | |
| Interaction | CANX interactions | HLA-A HLA-B HLA-C CDC123 GPX8 GUSB PRRC2C ASGR1 ACBD5 LRRC8A ECE1 | 2.58e-04 | 1261 | 51 | 11 | int:CANX |
| Interaction | NDUFA1 interactions | 2.59e-04 | 49 | 51 | 3 | int:NDUFA1 | |
| Interaction | HSP90AA1 interactions | IARS2 CDC123 PRRC2C ASGR1 DTX4 BTK LRRC8A UHRF1 NOS3 HSPB1 FBXW11 | 2.61e-04 | 1263 | 51 | 11 | int:HSP90AA1 |
| Interaction | PYGL interactions | 2.81e-04 | 125 | 51 | 4 | int:PYGL | |
| Interaction | PGAP4 interactions | 2.92e-04 | 51 | 51 | 3 | int:PGAP4 | |
| Interaction | BTAF1 interactions | 3.08e-04 | 128 | 51 | 4 | int:BTAF1 | |
| Interaction | GALNT6 interactions | 3.09e-04 | 52 | 51 | 3 | int:GALNT6 | |
| Interaction | AQP3 interactions | 3.39e-04 | 239 | 51 | 5 | int:AQP3 | |
| Interaction | AKAP8L interactions | 3.45e-04 | 240 | 51 | 5 | int:AKAP8L | |
| Interaction | SCO2 interactions | 3.67e-04 | 134 | 51 | 4 | int:SCO2 | |
| Interaction | IMMP1L interactions | 3.72e-04 | 244 | 51 | 5 | int:IMMP1L | |
| Interaction | MMGT1 interactions | 3.85e-04 | 381 | 51 | 6 | int:MMGT1 | |
| Interaction | PHB2 interactions | 3.98e-04 | 540 | 51 | 7 | int:PHB2 | |
| Interaction | UGT1A7 interactions | 4.06e-04 | 57 | 51 | 3 | int:UGT1A7 | |
| Interaction | ZFP41 interactions | 4.06e-04 | 57 | 51 | 3 | int:ZFP41 | |
| Interaction | POLE interactions | 4.21e-04 | 139 | 51 | 4 | int:POLE | |
| Interaction | SIDT2 interactions | 4.33e-04 | 140 | 51 | 4 | int:SIDT2 | |
| Interaction | ACSL4 interactions | 4.33e-04 | 140 | 51 | 4 | int:ACSL4 | |
| Interaction | PTPRO interactions | 4.69e-04 | 143 | 51 | 4 | int:PTPRO | |
| Interaction | NDUFA11 interactions | 4.72e-04 | 60 | 51 | 3 | int:NDUFA11 | |
| Cytoband | 6p21.3 | 2.04e-04 | 250 | 53 | 4 | 6p21.3 | |
| GeneFamily | Glycogen phosphorylases | 6.65e-09 | 3 | 35 | 3 | 437 | |
| GeneFamily | NADH:ubiquinone oxidoreductase supernumerary subunits | 2.60e-05 | 30 | 35 | 3 | 1150 | |
| GeneFamily | C1-set domain containing | 7.24e-05 | 42 | 35 | 3 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 8.34e-05 | 44 | 35 | 3 | 588 | |
| GeneFamily | Potassium voltage-gated channels | 2.71e-03 | 40 | 35 | 2 | 274 | |
| GeneFamily | C-type lectin domain family | 3.73e-03 | 47 | 35 | 2 | 494 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_ENDOTHELIAL_CELL_AGEING | 8.29e-07 | 383 | 52 | 8 | MM3687 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 1.76e-06 | 44 | 52 | 4 | MM3775 | |
| Coexpression | TABULA_MURIS_SENIS_SKIN_EPIDERMAL_CELL_AGEING | 3.16e-06 | 618 | 52 | 9 | MM3829 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 3.43e-06 | 324 | 52 | 7 | MM3701 | |
| Coexpression | TABULA_MURIS_SENIS_SKIN_BASAL_CELL_OF_EPIDERMIS_AGEING | REX1BD HLA-A HLA-B HLA-C CDC123 MRPS18B LRRC8A ECE1 NDUFB8 NDUFB9 CTSZ | 3.56e-06 | 1005 | 52 | 11 | MM3827 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 4.05e-06 | 16 | 52 | 3 | MM3766 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_FIBROBLAST_OF_LUNG_AGEING | 5.34e-06 | 224 | 52 | 6 | MM3767 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 5.78e-06 | 59 | 52 | 4 | MM3704 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 6.98e-06 | 19 | 52 | 3 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 6.98e-06 | 19 | 52 | 3 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 8.20e-06 | 20 | 52 | 3 | MM3682 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING | 8.59e-06 | 140 | 52 | 5 | MM3705 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 9.55e-06 | 21 | 52 | 3 | MM651 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_MONOCYTE_AGEING | 1.09e-05 | 147 | 52 | 5 | MM3707 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_STEM_CELL_AGEING | 1.10e-05 | 721 | 52 | 9 | MM3800 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 1.45e-05 | 24 | 52 | 3 | MM3773 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 1.64e-05 | 25 | 52 | 3 | MM672 | |
| Coexpression | FAN_OVARY_CL12_T_LYMPHOCYTE_NK_CELL_2 | 1.69e-05 | 161 | 52 | 5 | M41714 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_ENDOTHELIAL_CELL_OF_HEPATIC_SINUSOID_AGEING | 1.80e-05 | 418 | 52 | 7 | MM3752 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_BRAIN_PERICYTE_AGEING | 2.00e-05 | 778 | 52 | 9 | MM3686 | |
| Coexpression | TABULA_MURIS_SENIS_LARGE_INTESTINE_ENTEROCYTE_OF_EPITHELIUM_OF_LARGE_INTESTINE_AGEING | REX1BD HLA-A HLA-B HLA-C CDC123 COX16 ECE1 NDUFB3 NDUFB8 NDUFB9 CTSZ | 2.59e-05 | 1241 | 52 | 11 | MM3735 |
| Coexpression | KIM_LRRC3B_TARGETS | 2.88e-05 | 30 | 52 | 3 | M17363 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 3.18e-05 | 31 | 52 | 3 | MM3729 | |
| Coexpression | FAN_OVARY_CL13_MONOCYTE_MACROPHAGE | 3.22e-05 | 458 | 52 | 7 | M41715 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 3.53e-05 | 93 | 52 | 4 | MM1185 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 3.63e-05 | 1055 | 52 | 10 | MM3677 | |
| Coexpression | SIRNA_EIF4GI_UP | 3.84e-05 | 95 | 52 | 4 | M2847 | |
| Coexpression | DURAND_STROMA_NS_UP | 4.13e-05 | 194 | 52 | 5 | MM962 | |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_ASTROCYTES | 4.45e-05 | 326 | 52 | 6 | M39074 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 4.61e-05 | 35 | 52 | 3 | MM674 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 5.27e-05 | 103 | 52 | 4 | MM476 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_PROMONOCYTE_AGEING | 5.47e-05 | 104 | 52 | 4 | MM3812 | |
| Coexpression | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN | 5.76e-05 | 6 | 52 | 2 | M7182 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 6.40e-05 | 39 | 52 | 3 | MM3758 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 6.40e-05 | 39 | 52 | 3 | MM3725 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_STROMAL_CELL_AGEING | 6.49e-05 | 349 | 52 | 6 | MM3790 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 6.83e-05 | 703 | 52 | 8 | MM1055 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE | 6.91e-05 | 40 | 52 | 3 | M41037 | |
| Coexpression | TABULA_MURIS_SENIS_SKIN_BULGE_KERATINOCYTE_AGEING | 7.07e-05 | 915 | 52 | 9 | MM3828 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_MYELOID_MICROGLIAL_CELL_AGEING | 7.24e-05 | 356 | 52 | 6 | MM3684 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 7.44e-05 | 41 | 52 | 3 | MM710 | |
| Coexpression | ZHANG_UTERUS_C9_DENDRITIC_CELL | 7.82e-05 | 114 | 52 | 4 | MM16615 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 8.07e-05 | 720 | 52 | 8 | MM3700 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 8.59e-05 | 43 | 52 | 3 | MM1204 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | 8.88e-05 | 228 | 52 | 5 | MM3676 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 1.05e-04 | 46 | 52 | 3 | MM3712 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 1.15e-04 | 126 | 52 | 4 | MM3711 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VALVE_CELL_AGEING | 1.15e-04 | 126 | 52 | 4 | MM3709 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_FIBROBLAST_AGEING | 1.19e-04 | 127 | 52 | 4 | MM3856 | |
| Coexpression | FAN_OVARY_CL4_T_LYMPHOCYTE_NK_CELL_1 | 1.27e-04 | 246 | 52 | 5 | M41706 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 1.27e-04 | 49 | 52 | 3 | MM1287 | |
| Coexpression | PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN | 1.27e-04 | 49 | 52 | 3 | M8341 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 1.35e-04 | 50 | 52 | 3 | MM3805 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 1.38e-04 | 132 | 52 | 4 | MM841 | |
| Coexpression | TABULA_MURIS_SENIS_LARGE_INTESTINE_INTESTINAL_CRYPT_STEM_CELL_AGEING | 1.43e-04 | 403 | 52 | 6 | MM3738 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 1.52e-04 | 52 | 52 | 3 | MM3808 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 1.55e-04 | 136 | 52 | 4 | MM3747 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS | 1.59e-04 | 137 | 52 | 4 | M41743 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 1.59e-04 | 137 | 52 | 4 | MM16612 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_IMMATURE_B_CELL_AGEING | 1.61e-04 | 259 | 52 | 5 | MM3801 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_PROFESSIONAL_ANTIGEN_PRESENTING_CELL_AGEING | 1.88e-04 | 143 | 52 | 4 | MM3673 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 1.90e-04 | 56 | 52 | 3 | MM3852 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 2.00e-04 | 57 | 52 | 3 | MM3716 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 2.03e-04 | 146 | 52 | 4 | MM856 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 2.21e-04 | 59 | 52 | 3 | MM3688 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 2.26e-04 | 439 | 52 | 6 | M39054 | |
| Coexpression | TABULA_MURIS_SENIS_LARGE_INTESTINE_LARGE_INTESTINE_GOBLET_CELL_AGEING | 2.27e-04 | 837 | 52 | 8 | MM3739 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE | 2.33e-04 | 60 | 52 | 3 | M40971 | |
| Coexpression | GSE6259_33D1_POS_DC_VS_BCELL_UP | 2.55e-04 | 155 | 52 | 4 | M6751 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | 2.61e-04 | 1088 | 52 | 9 | MM3699 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 2.68e-04 | 289 | 52 | 5 | M2196 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_1_DN | 2.82e-04 | 64 | 52 | 3 | M2237 | |
| Coexpression | YU_MYC_TARGETS_DN | 3.37e-04 | 68 | 52 | 3 | MM632 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_ASTROCYTE_AGEING | 3.41e-04 | 474 | 52 | 6 | MM3685 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_OLIGODENDROCYTE_AGEING | 3.65e-04 | 1139 | 52 | 9 | MM3690 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 3.75e-04 | 681 | 52 | 7 | M5314 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 3.77e-04 | 1144 | 52 | 9 | MM3843 | |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 3.86e-04 | 313 | 52 | 5 | M39128 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 4.15e-04 | 73 | 52 | 3 | M11428 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 4.32e-04 | 74 | 52 | 3 | MM3796 | |
| Coexpression | TABULA_MURIS_SENIS_THYMUS_THYMOCYTE_AGEING | 4.47e-04 | 701 | 52 | 7 | MM3849 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 4.50e-04 | 75 | 52 | 3 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 4.50e-04 | 75 | 52 | 3 | MM3718 | |
| Coexpression | SANA_RESPONSE_TO_IFNG_UP | 4.67e-04 | 76 | 52 | 3 | M4551 | |
| Coexpression | WU_CELL_MIGRATION | 4.79e-04 | 183 | 52 | 4 | M2001 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_AORTIC_ENDOTHELIAL_CELL_AGEING | 4.84e-04 | 329 | 52 | 5 | MM3671 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 4.99e-04 | 185 | 52 | 4 | MM1072 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ALVEOLAR_MACROPHAGE_AGEING | 5.09e-04 | 186 | 52 | 4 | MM3762 | |
| Coexpression | ZHANG_UTERUS_C5_MACROPHAGE | 5.20e-04 | 187 | 52 | 4 | MM16611 | |
| Coexpression | ZHANG_UTERUS_C12_MONOCYTE | 5.30e-04 | 188 | 52 | 4 | MM16618 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 5.37e-04 | 723 | 52 | 7 | MM3672 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 5.52e-04 | 190 | 52 | 4 | MM3832 | |
| Coexpression | PHONG_TNF_RESPONSE_NOT_VIA_P38 | 5.70e-04 | 341 | 52 | 5 | M2504 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_UP | 5.74e-04 | 192 | 52 | 4 | MM752 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 5.84e-04 | 82 | 52 | 3 | MM3777 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 5.84e-04 | 82 | 52 | 3 | MM3858 | |
| Coexpression | MENON_FETAL_KIDNEY_10_IMMUNE_CELLS | 6.05e-04 | 83 | 52 | 3 | M39260 | |
| Coexpression | SANA_TNF_SIGNALING_UP | 6.05e-04 | 83 | 52 | 3 | M17466 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP | 6.08e-04 | 195 | 52 | 4 | M5318 | |
| Coexpression | GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN | 6.20e-04 | 196 | 52 | 4 | M8143 | |
| ToppCell | 390C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-07 | 198 | 52 | 6 | 36e49a4860b37d674511120b9e0366efa1e08480 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-07 | 199 | 52 | 6 | 7d853204ec84b7ea716556207223be18b6c3754e | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-07 | 199 | 52 | 6 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 2.05e-06 | 178 | 52 | 5 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 185 | 52 | 5 | c3105978d971da7d0fad1a717ee29afee5ed6357 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 185 | 52 | 5 | 4cfef50aeed5b3000ce5e864a41c13740b8267b1 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 185 | 52 | 5 | 09256c6f42f59b7eb89160b2ea706172a5b743be | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 193 | 52 | 5 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 193 | 52 | 5 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 3.12e-06 | 194 | 52 | 5 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.20e-06 | 195 | 52 | 5 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-06 | 197 | 52 | 5 | 2e3d64648a1e4f01b9256a96b94b8a640ee1824c | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-06 | 197 | 52 | 5 | d9e196c8b4a6ede4733946dbdba3331534954beb | |
| ToppCell | nucseq-Immune|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-06 | 197 | 52 | 5 | b7c2c08af97a896315c105269ffb5295e20b225a | |
| ToppCell | ASK428-Immune|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.45e-06 | 198 | 52 | 5 | 777ee3e46943f8ec76ffc0f42be0e2658c0bd57f | |
| ToppCell | Endoth-Vasc|World / shred by cell class for parenchyma | 3.45e-06 | 198 | 52 | 5 | 067101d070cfaf84c7d16c6e517f8946690ad502 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.53e-06 | 199 | 52 | 5 | 7cbd98dd10c91584dee04593910031e90c1340b8 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial-oRG/Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.53e-06 | 199 | 52 | 5 | 0b96fad1be02f0fe7a608207770cc56a6b6b291e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-06 | 199 | 52 | 5 | 05777e92344aedabfb5a72207c6632dc64205534 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_monocytic-monocyte-promonocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.53e-06 | 199 | 52 | 5 | afa709fe1cf715d85c7fb07b42065890b9010265 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.53e-06 | 199 | 52 | 5 | d2783e69da653184e38dc6d85b23521790fa24b8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-06 | 199 | 52 | 5 | e6715288a586631676722f2323f0d833431161cf | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.62e-06 | 200 | 52 | 5 | 62e9ca7cf4f49fc8957740acee41a1e530f10541 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.62e-06 | 200 | 52 | 5 | 4984d27b3768be3b8fca3391cd2b7ab1749e2913 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-06 | 200 | 52 | 5 | 4477591efada4007bab1f689017e3ac285267d29 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-06 | 200 | 52 | 5 | 3007583eaad3a5ae2df010513d3e4df59155123d | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-06 | 200 | 52 | 5 | 9f1626a7e1bd00977a5c316cafbdf654b52bad94 | |
| ToppCell | severe-cDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.62e-06 | 200 | 52 | 5 | 26e04ea276dbca5cde48335c401269c7123b54d2 | |
| ToppCell | distal-Endothelial-Capillary-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.62e-06 | 200 | 52 | 5 | ab96d3d801373459a2503ccfb665dc3f43bfb5a1 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.74e-05 | 161 | 52 | 4 | 2de213169fe1965ceaea545297228117c81d9909 | |
| ToppCell | Myeloid|World / shred on cell class and cell subclass (v4) | 3.74e-05 | 161 | 52 | 4 | aee407d3739dba2d5216dcdb1579e7e4f483123d | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B2|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-05 | 163 | 52 | 4 | 036e65de0f8fc391f3e4d299bf4c05ee5c3b5a37 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.93e-05 | 163 | 52 | 4 | ec8336b68c8369e27d507c04c827be07bb48a7f6 | |
| ToppCell | COVID-19_Mild-PLT_3|COVID-19_Mild / Disease Group and Platelet Clusters | 4.62e-05 | 170 | 52 | 4 | 5ac1252ae3c026a506cfe26e3d119276fe364661 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Pro-B/Pre-B_transition|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.06e-05 | 174 | 52 | 4 | 183ff6b93b7fbe43d83e12427e234bd7d8745961 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-05 | 175 | 52 | 4 | b9931455f232de3029510993015bb13b70dc18c9 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.29e-05 | 176 | 52 | 4 | 270d7908dbd84028958d257f94941dc685e20255 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.41e-05 | 177 | 52 | 4 | fd739ae4a574b72dc26a2a9ff4ef988454298ead | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 5.41e-05 | 177 | 52 | 4 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.41e-05 | 177 | 52 | 4 | 1e7b4c0e41649d57a2c219a3b7e693538b8b34e4 | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-05 | 178 | 52 | 4 | 8017aaecd6275d8173c516f6f3a68ea991f3c1b0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-05 | 178 | 52 | 4 | c4a2e9a440e941e82bb35abefa054e07ad250d45 | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-05 | 178 | 52 | 4 | 46333db0d205580189062bf9df839c97196ad161 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-05 | 179 | 52 | 4 | d56fa2a0b119d51a8d41b00fbbd7dfddefeb279c | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-05 | 179 | 52 | 4 | e0542694fa79d67f67be6f85b4fa6d18f7523253 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-05 | 179 | 52 | 4 | 83343b68977969c7978acd930a66fc7c44df6a15 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.90e-05 | 181 | 52 | 4 | 0756d7d315b8cdd07a3cf6cdfc8a0679786b8e6a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.90e-05 | 181 | 52 | 4 | b09947d2d7b21f96d98b87ceb6f467ea329c4092 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.90e-05 | 181 | 52 | 4 | 3f0d88e9506d66d4e71b88c50d5187302065930f | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.03e-05 | 182 | 52 | 4 | 94d061b7b5ebbfc564c644bc8b2d52341927145d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.03e-05 | 182 | 52 | 4 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.16e-05 | 183 | 52 | 4 | 4cc0961a67de76b8d756cd9ffcaa98e3fe3c3a69 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.29e-05 | 184 | 52 | 4 | 73eaac74a88bf5fd23d88035fac398ac43b268c5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.29e-05 | 184 | 52 | 4 | 65f651d4b93ed0b52f526d3f517d92b6c62aaec3 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.29e-05 | 184 | 52 | 4 | 8e5fc2bdd3071e782aa8c56b8a39f8ea8f03f623 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.29e-05 | 184 | 52 | 4 | 9001d35cdde061d06f8545b3cee942d1299129db | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-05 | 185 | 52 | 4 | 7f46ea82a663181957f88e4e83114aef8a78820c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-05 | 185 | 52 | 4 | 956fb0043c0c3e4e5c4d6f58ff95faf6209c380e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.42e-05 | 185 | 52 | 4 | fb84fcf7f51f53489bcb3962fa9cb483e48257ed | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 6.42e-05 | 185 | 52 | 4 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-05 | 186 | 52 | 4 | ba6ba75218efc26371cea24ddbb0e9b3e3f421ac | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.56e-05 | 186 | 52 | 4 | 422d24e3e1a9397bb7d5c7ef75de2fd7ae8e136d | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 6.56e-05 | 186 | 52 | 4 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-05 | 186 | 52 | 4 | a58c9d1567da0961e0e295a156773d2252ee5a1a | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-05 | 186 | 52 | 4 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-05 | 186 | 52 | 4 | 65e25a9dcef5fc71510aaf170e220deef5b2feb2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.56e-05 | 186 | 52 | 4 | 65da0666a10a59f8cc379589860a2e98fe487754 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.56e-05 | 186 | 52 | 4 | dc84fef1ca2f5d5d818b76a3321559e87d1c4a4d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-05 | 186 | 52 | 4 | e4f1259725160719e5fd13d76e5a707efed70013 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B-GC_B_(I)|GI_small-bowel / Manually curated celltypes from each tissue | 6.69e-05 | 187 | 52 | 4 | a92cade2a835f5fce8de1e14650af8cdd818c296 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 187 | 52 | 4 | 3e25c15fa29f8c738044914e8b3420d5713f18d9 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.69e-05 | 187 | 52 | 4 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 187 | 52 | 4 | 965584ee44669a72866a20ddf7f657bc5a7f7a8b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 187 | 52 | 4 | a7ef179e6561e17cafae10e1843bf82ac3ae0c89 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.83e-05 | 188 | 52 | 4 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 6.83e-05 | 188 | 52 | 4 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | critical-Epithelial-IRC-IFNG_responsive_cell|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.83e-05 | 188 | 52 | 4 | 023f6e34c2db8657d25e70a97b7b9d45166c13ad | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Late_pro-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.83e-05 | 188 | 52 | 4 | 1f24bb9cac5e74323ef93770442a869a89e07cf1 | |
| ToppCell | facs-Kidney-nan-24m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 9d02a824bba59ea0660439f0510d843568e9d8c3 | |
| ToppCell | facs-Kidney-nan-24m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 5f8d4b61296c71b32362432a9ce4c1c3aaeb278d | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | d52fc275976a625b014fa36f62ef07dddf1ffa43 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 199cec36fbbc1288771b9edf22143c34ab990af1 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | d9c2adbbe3e40eb8d57200b6411533e6685ea0d2 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 476226787c8ea0c9834a6f4c99ac7091cc20a455 | |
| ToppCell | facs-Kidney-nan-24m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 18f82764b32496e54d1a604a531b261651c5e110 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 3fe69bad6427e41b8d2dae450828cc21e9c3b3ad | |
| ToppCell | TCGA-Kidney-Primary_Tumor|TCGA-Kidney / Sample_Type by Project: Shred V9 | 7.12e-05 | 190 | 52 | 4 | 773c4575d22483d89a54c8db0e09905deed0d088 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 7.12e-05 | 190 | 52 | 4 | e3696e7542424c03d0a41136b10729a3dd09549a | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 0a211e7dc515926b488f04c6248f6c7e61c2da87 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|COPD / Disease state, Lineage and Cell class | 7.12e-05 | 190 | 52 | 4 | 006e31606d637033bc81333816ee332773d36b08 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.12e-05 | 190 | 52 | 4 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | b0c9dae8189d407c94964c6bfe3ef92035245357 | |
| ToppCell | facs-Heart-LA-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 911b93c4c828ef2d867b91a5eced2dc12a1baf27 | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | ee63dc04e91ad49aa7820c98e97261176ecebaa6 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 7.12e-05 | 190 | 52 | 4 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 3639eb9b887a2d76949cad4a2586524fe0e1015f | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 0e50808bfc3d0820524c8470ae3e8250819d65b2 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 90e494cbfbed33a3a0d29bb7dae83f0c81580bcf | |
| Computational | Genes in the cancer module 293. | 8.09e-06 | 12 | 37 | 3 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 1.33e-05 | 14 | 37 | 3 | MODULE_143 | |
| Computational | Neighborhood of CD48 | 1.74e-04 | 32 | 37 | 3 | GNF2_CD48 | |
| Computational | Neighborhood of RAB10 | 3.17e-04 | 176 | 37 | 5 | GCM_RAB10 | |
| Computational | Energy pathways. | 3.54e-04 | 99 | 37 | 4 | MODULE_43 | |
| Computational | Neighborhood of INPP5D | 4.21e-04 | 43 | 37 | 3 | GNF2_INPP5D | |
| Computational | Neighborhood of HLA-C | 5.49e-04 | 47 | 37 | 3 | GNF2_HLA_C | |
| Computational | Neighborhood of PTPN6 | 5.49e-04 | 47 | 37 | 3 | GNF2_PTPN6 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.58e-04 | 50 | 37 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.58e-04 | 50 | 37 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC | |
| Computational | Genes in the cancer module 25. | 8.78e-04 | 13 | 37 | 2 | MODULE_25 | |
| Computational | Neighborhood of CD53 | 1.02e-03 | 58 | 37 | 3 | GNF2_CD53 | |
| Computational | Genes in the cancer module 27. | 1.22e-03 | 355 | 37 | 6 | MODULE_27 | |
| Computational | Neighborhood of PTPRC | 1.61e-03 | 68 | 37 | 3 | GNF2_PTPRC | |
| Computational | Neighborhood of STAT6 | 2.48e-03 | 79 | 37 | 3 | GNF2_STAT6 | |
| Drug | 3,5-dimethylphenyl isocyanate | 1.12e-08 | 3 | 52 | 3 | CID000521488 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 1.12e-08 | 3 | 52 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 1.12e-08 | 3 | 52 | 3 | CID000191554 | |
| Drug | hydan | 1.12e-08 | 3 | 52 | 3 | CID000008360 | |
| Drug | EHMF | 1.12e-08 | 3 | 52 | 3 | CID000033931 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 1.12e-08 | 3 | 52 | 3 | CID000147839 | |
| Drug | pyridoxal 5'-methylenephosphonate | 1.12e-08 | 3 | 52 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 1.12e-08 | 3 | 52 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 1.12e-08 | 3 | 52 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 1.12e-08 | 3 | 52 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 1.12e-08 | 3 | 52 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 1.12e-08 | 3 | 52 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 1.12e-08 | 3 | 52 | 3 | CID000446801 | |
| Drug | NSC758405 | 1.12e-08 | 3 | 52 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 1.12e-08 | 3 | 52 | 3 | CID000151920 | |
| Drug | riboflavin tetraacetate | 1.12e-08 | 3 | 52 | 3 | CID000094186 | |
| Drug | pyridoxal phosphoglucose | 1.12e-08 | 3 | 52 | 3 | CID000196007 | |
| Drug | 2,5-dimethyl-3-furanone | 1.12e-08 | 3 | 52 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 1.12e-08 | 3 | 52 | 3 | CID000011459 | |
| Drug | D-Au | 2.21e-08 | 77 | 52 | 6 | CID000277822 | |
| Drug | galocitabine | 4.49e-08 | 4 | 52 | 3 | CID000065950 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 4.49e-08 | 4 | 52 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 4.49e-08 | 4 | 52 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 4.49e-08 | 4 | 52 | 3 | CID000094262 | |
| Drug | Mem-CC | 4.49e-08 | 4 | 52 | 3 | CID003081269 | |
| Drug | 5-deoxyribose-1-phosphate | 4.49e-08 | 4 | 52 | 3 | CID000135786 | |
| Drug | ingliforib | 4.49e-08 | 4 | 52 | 3 | CID006451325 | |
| Drug | uric acid riboside | 4.49e-08 | 4 | 52 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 4.49e-08 | 4 | 52 | 3 | CID000125259 | |
| Drug | BCIp4A | 4.49e-08 | 4 | 52 | 3 | CID000192417 | |
| Drug | pyridoxal diphosphate | 4.49e-08 | 4 | 52 | 3 | CID000125696 | |
| Drug | 3'-chloromethotrexate | 4.49e-08 | 4 | 52 | 3 | CID000097703 | |
| Drug | 1-GlcNAc | 7.23e-08 | 18 | 52 | 4 | CID000151446 | |
| Drug | heptulose-2-P | 1.12e-07 | 5 | 52 | 3 | CID000124823 | |
| Drug | m-anisidine | 1.12e-07 | 5 | 52 | 3 | CID000010824 | |
| Drug | 6-FPLP | 1.12e-07 | 5 | 52 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 1.12e-07 | 5 | 52 | 3 | CID009576855 | |
| Drug | 2-hydroxypropylphosphonate | 1.12e-07 | 5 | 52 | 3 | CID000441028 | |
| Drug | DHPBU | 1.12e-07 | 5 | 52 | 3 | CID000125914 | |
| Drug | 6-FDPL | 1.12e-07 | 5 | 52 | 3 | CID000129578 | |
| Drug | 5'-isobutylthioinosine | 1.12e-07 | 5 | 52 | 3 | CID003080910 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 1.12e-07 | 5 | 52 | 3 | CID003082179 | |
| Drug | GlcMan | 1.12e-07 | 5 | 52 | 3 | CID000152120 | |
| Drug | U66985 | 1.12e-07 | 5 | 52 | 3 | CID000127224 | |
| Drug | indirubin-5-sulphonate | 1.12e-07 | 5 | 52 | 3 | CID005288641 | |
| Drug | AC1O3M08 | 1.12e-07 | 5 | 52 | 3 | CID006331955 | |
| Drug | AC1LCUXJ | 1.12e-07 | 5 | 52 | 3 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 1.12e-07 | 5 | 52 | 3 | CID000080578 | |
| Drug | etafenone | 1.12e-07 | 5 | 52 | 3 | CID000003275 | |
| Drug | ddEtUrd | 1.12e-07 | 5 | 52 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 1.12e-07 | 5 | 52 | 3 | CID000125618 | |
| Drug | I0329 | 1.41e-07 | 21 | 52 | 4 | CID000439668 | |
| Drug | maltosaccharide | 1.72e-07 | 22 | 52 | 4 | CID005461034 | |
| Drug | ginsenoside | 2.07e-07 | 23 | 52 | 4 | CID000092797 | |
| Drug | CV-araU | 2.24e-07 | 6 | 52 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 2.24e-07 | 6 | 52 | 3 | CID003005944 | |
| Drug | Carbocyclic Bvdc | 2.24e-07 | 6 | 52 | 3 | CID006438602 | |
| Drug | DNPP | 2.24e-07 | 6 | 52 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 2.24e-07 | 6 | 52 | 3 | CID000082693 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 2.24e-07 | 6 | 52 | 3 | CID000152984 | |
| Drug | EdUMP | 2.24e-07 | 6 | 52 | 3 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 2.24e-07 | 6 | 52 | 3 | CID000126430 | |
| Drug | NSC-97433 | 2.24e-07 | 6 | 52 | 3 | CID000001803 | |
| Drug | 5-n-propylthioadenosine | 2.24e-07 | 6 | 52 | 3 | CID000656428 | |
| Drug | AzddCyd | 2.24e-07 | 6 | 52 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 2.24e-07 | 6 | 52 | 3 | CID000065561 | |
| Drug | AR-L57 | 2.24e-07 | 6 | 52 | 3 | CID000156890 | |
| Drug | Carbocyclic Ivdu | 2.24e-07 | 6 | 52 | 3 | CID006439191 | |
| Drug | BrVarafUTP | 2.48e-07 | 24 | 52 | 4 | CID005273539 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 3.91e-07 | 7 | 52 | 3 | CID006439607 | |
| Drug | 6-fluoropyridoxal | 3.91e-07 | 7 | 52 | 3 | CID003080803 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 3.91e-07 | 7 | 52 | 3 | CID000356019 | |
| Drug | heptenitol | 3.91e-07 | 7 | 52 | 3 | CID000188267 | |
| Drug | AC1L3372 | 3.91e-07 | 7 | 52 | 3 | CID000108025 | |
| Drug | 1 Gpt | 3.91e-07 | 7 | 52 | 3 | CID000101247 | |
| Drug | formycins | 3.91e-07 | 7 | 52 | 3 | CID000512867 | |
| Drug | Promonta | 3.91e-07 | 7 | 52 | 3 | CID000108494 | |
| Drug | 5'-methylthioinosine | 3.91e-07 | 7 | 52 | 3 | CID000161214 | |
| Drug | hydantocidin | 3.91e-07 | 7 | 52 | 3 | CID000125429 | |
| Drug | FUTP | 4.08e-07 | 27 | 52 | 4 | CID000122060 | |
| Drug | cyclobuta | 6.24e-07 | 8 | 52 | 3 | CID000122100 | |
| Drug | AC1NUVX5 | 6.24e-07 | 8 | 52 | 3 | CID005461894 | |
| Drug | 6-methylpurine | 6.24e-07 | 8 | 52 | 3 | CID005287547 | |
| Drug | amorphin | 6.24e-07 | 8 | 52 | 3 | CID000122792 | |
| Drug | Etafenone [inn] | 6.24e-07 | 8 | 52 | 3 | CID000066659 | |
| Drug | diethylamine NONOate | 6.36e-07 | 72 | 52 | 5 | CID000107754 | |
| Drug | 2,5-anhydro-D-mannitol | 7.27e-07 | 31 | 52 | 4 | CID000001494 | |
| Drug | 6-benzyl-2-thiouracil | 9.35e-07 | 9 | 52 | 3 | CID000685814 | |
| Drug | 5'-methylthiotubercidin | 9.35e-07 | 9 | 52 | 3 | CID000188350 | |
| Drug | alpha-maltosyl fluoride | 9.35e-07 | 9 | 52 | 3 | CID000194237 | |
| Drug | 5-Iodoribose 1-phosphate | 9.35e-07 | 9 | 52 | 3 | CID003035973 | |
| Drug | 5'-iodo-5'-deoxyadenosine | 9.35e-07 | 9 | 52 | 3 | CID000107502 | |
| Drug | NSC603722 | 9.49e-07 | 78 | 52 | 5 | CID005037551 | |
| Drug | sodium sulfate | 1.01e-06 | 79 | 52 | 5 | CID000024436 | |
| Drug | 8-azidoadenosine 5'-monophosphate | 1.33e-06 | 10 | 52 | 3 | CID000124726 | |
| Drug | 2,6-dihydroxypyridine | 1.33e-06 | 10 | 52 | 3 | CID000069371 | |
| Drug | 6-methyluridine | 1.33e-06 | 10 | 52 | 3 | CID000092887 | |
| Drug | UDP-pyridoxal | 1.33e-06 | 10 | 52 | 3 | CID000126789 | |
| Drug | nojirimycin | 1.69e-06 | 38 | 52 | 4 | CID000065242 | |
| Drug | L-BVAU | 1.69e-06 | 38 | 52 | 4 | CID000667554 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.80e-07 | 7 | 52 | 3 | DOID:0081267 (implicated_via_orthology) | |
| Disease | beta-2 microglobulin measurement | 8.43e-07 | 11 | 52 | 3 | EFO_0005197 | |
| Disease | – | 3.05e-06 | 2 | 52 | 2 | 608579 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 3.05e-06 | 2 | 52 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 3.05e-06 | 2 | 52 | 2 | cv:CN077964 | |
| Disease | agammaglobulinemia (is_implicated_in) | 9.13e-06 | 3 | 52 | 2 | DOID:2583 (is_implicated_in) | |
| Disease | vulva cancer (is_implicated_in) | 1.82e-05 | 4 | 52 | 2 | DOID:1245 (is_implicated_in) | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 1.82e-05 | 4 | 52 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.83e-05 | 29 | 52 | 3 | C1274933 | |
| Disease | Toxic Epidermal Necrolysis | 1.83e-05 | 29 | 52 | 3 | C0014518 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.83e-05 | 29 | 52 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.83e-05 | 29 | 52 | 3 | C3658302 | |
| Disease | MITOCHONDRIAL COMPLEX I DEFICIENCY | 2.03e-05 | 30 | 52 | 3 | C1838979 | |
| Disease | Stevens-Johnson Syndrome | 2.03e-05 | 30 | 52 | 3 | C0038325 | |
| Disease | allergic asthma (is_implicated_in) | 3.04e-05 | 5 | 52 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | scoliosis (implicated_via_orthology) | 3.04e-05 | 5 | 52 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | retinopathy of prematurity (is_implicated_in) | 6.36e-05 | 7 | 52 | 2 | DOID:13025 (is_implicated_in) | |
| Disease | Erythema nodosum | 1.09e-04 | 9 | 52 | 2 | HP_0012219 | |
| Disease | Essential hypertension | 1.36e-04 | 10 | 52 | 2 | cv:C0085580 | |
| Disease | Essential hypertension, genetic | 1.36e-04 | 10 | 52 | 2 | cv:CN305331 | |
| Disease | HYPERTENSION, ESSENTIAL | 1.36e-04 | 10 | 52 | 2 | 145500 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.60e-04 | 291 | 52 | 5 | EFO_0008317, EFO_0020946 | |
| Disease | acute kidney failure (biomarker_via_orthology) | 1.73e-04 | 61 | 52 | 3 | DOID:3021 (biomarker_via_orthology) | |
| Disease | Essential Hypertension | 1.99e-04 | 12 | 52 | 2 | C0085580 | |
| Disease | Agammaglobulinemia | 1.99e-04 | 12 | 52 | 2 | C0001768 | |
| Disease | Malignant Glioma | 2.60e-04 | 70 | 52 | 3 | C0555198 | |
| Disease | mixed gliomas | 2.60e-04 | 70 | 52 | 3 | C0259783 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 3.15e-04 | 15 | 52 | 2 | EFO_0801746 | |
| Disease | Hypogammaglobulinemia | 4.07e-04 | 17 | 52 | 2 | C0086438 | |
| Disease | essential hypertension (is_implicated_in) | 4.58e-04 | 18 | 52 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | susceptibility to Mycobacterium tuberculosis infection measurement | 4.76e-04 | 86 | 52 | 3 | EFO_0008407 | |
| Disease | Glioma | 4.93e-04 | 87 | 52 | 3 | C0017638 | |
| Disease | cardiomyopathy (is_implicated_in) | 5.11e-04 | 19 | 52 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | COVID-19 (is_implicated_in) | 6.26e-04 | 21 | 52 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 6.69e-04 | 225 | 52 | 4 | EFO_0008317, EFO_0020947 | |
| Disease | coronary artery disease (is_implicated_in) | 7.40e-04 | 100 | 52 | 3 | DOID:3393 (is_implicated_in) | |
| Disease | Adenoid Cystic Carcinoma | 7.40e-04 | 100 | 52 | 3 | C0010606 | |
| Disease | HIV Coinfection | 8.06e-04 | 103 | 52 | 3 | C4505456 | |
| Disease | HIV Infections | 8.06e-04 | 103 | 52 | 3 | C0019693 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 8.38e-04 | 239 | 52 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | Myocardial Failure | 9.75e-04 | 110 | 52 | 3 | C1959583 | |
| Disease | Congestive heart failure | 9.75e-04 | 110 | 52 | 3 | C0018802 | |
| Disease | Heart failure | 9.75e-04 | 110 | 52 | 3 | C0018801 | |
| Disease | Left-Sided Heart Failure | 9.75e-04 | 110 | 52 | 3 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 9.75e-04 | 110 | 52 | 3 | C0235527 | |
| Disease | Heart Decompensation | 9.75e-04 | 110 | 52 | 3 | C1961112 | |
| Disease | Glycogen Storage Disease | 1.04e-03 | 27 | 52 | 2 | C0017919 | |
| Disease | tuberculosis (is_implicated_in) | 1.12e-03 | 28 | 52 | 2 | DOID:399 (is_implicated_in) | |
| Disease | lymphocyte measurement | 1.17e-03 | 117 | 52 | 3 | EFO_0803546 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 1.44e-03 | 126 | 52 | 3 | EFO_0004611, EFO_0010351 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 1.75e-03 | 35 | 52 | 2 | DOID:700 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGFKNWRPEQPDDWY | 231 | P07306 | |
| YPWEWGEKRISTPRP | 311 | Q902F8 | |
| YLSPADLPKSWDWRN | 56 | Q9UBR2 | |
| WWRARDKNGQEGYIP | 251 | Q06187 | |
| YRIWQRDLANDPSWP | 1151 | Q4VNC1 | |
| SRPGFWDPIGRYKWD | 86 | Q5T8D3 | |
| PEDYIRWEDAWAIGP | 566 | Q14832 | |
| DDWKNIRGPRPWEDP | 76 | Q9P0S2 | |
| EWLNEHGRWRPYSPA | 11 | Q9Y2E6 | |
| AWELPKRAYSRKPWD | 1161 | Q68CQ1 | |
| LRDPWGRNEAWRYMG | 41 | O43676 | |
| ADTQPAYRILKPWWD | 11 | Q8IWT6 | |
| PRAPWVEQEGPEYWD | 71 | P10321 | |
| EWGPAAWPEDKRARL | 296 | Q96B70 | |
| PLWKGLSERRGWDQY | 176 | Q9UKB1 | |
| YPESARRDWVREWPG | 1091 | Q6ZR08 | |
| GWYRKLCPRLDDPAW | 571 | P54098 | |
| LPPWDPKDYSARWNE | 86 | Q9UL01 | |
| LRGPSWDPFRDWYPH | 11 | P04792 | |
| RDPWYSWDQPGLRLN | 86 | O95169 | |
| LSRRNPSYPWLWEDG | 206 | P78380 | |
| SWRGNEPEEWIPRTY | 1011 | Q9C091 | |
| PRAPWIEQEGPEYWD | 71 | P01889 | |
| DPRRYEEWKWFRCPT | 896 | P29474 | |
| GPRCPLYTWRAEEWQ | 1551 | Q9P2N4 | |
| IRGLDWKWRDQDGSP | 1281 | Q9ULT8 | |
| RWQPRIWALFEDPYS | 171 | P48547 | |
| LYDLPREPKDAWWCQ | 376 | Q99704 | |
| VFPKLNWSAPRDAYW | 101 | O75794 | |
| EQWYRRPLWESGPTV | 61 | P08236 | |
| PRAPWIEQEGPEYWD | 71 | P04439 | |
| QGREYDKDGNLRPWW | 616 | P42892 | |
| EPRWNFWKYLVNPEG | 161 | Q8TED1 | |
| LRDPSRPWGKDNYWM | 181 | Q9C009 | |
| PQFKFWAWDPEEERR | 761 | Q9UPQ0 | |
| PRVAEWRYGPARLWY | 336 | P21675 | |
| PARKEGDLPPLWWYI | 156 | Q9Y6M9 | |
| PPRTYWKEARERDWF | 1166 | Q9Y520 | |
| WKEARERDWFPDQGY | 1171 | Q9Y520 | |
| SKEPPYGADVLRWWV | 686 | Q9NSE4 | |
| PYGWRQSEDPRAWKT | 796 | Q9UP95 | |
| LCQPEWRYWKRNGPE | 381 | Q9NQ32 | |
| PWYNWKQPPERELSR | 201 | Q9Y676 | |
| DDWLRYGNPWEKARP | 181 | P11217 | |
| TEARGREEPAWPWKD | 21 | Q96EN9 | |
| DDWLRYGNPWEKARP | 181 | P11216 | |
| DPLAYWEKKREAWPP | 211 | Q96FA7 | |
| YRWQGRRWEPSGKAE | 151 | O95947 | |
| GWKWNRPGDRLLDLD | 136 | Q9NZI7 | |
| WRYLLRRDDDEPGPW | 576 | Q96T88 | |
| KGKEWPEFVRNYAPW | 446 | Q2TBF2 | |
| SAWPWEEKPRYLGPV | 21 | Q86UQ0 | |
| DDWLRYGNPWEKSRP | 181 | P06737 | |
| RWQPRVWALFEDPYS | 271 | Q14003 |